-
Something wrong with this record ?
Changes in glucose-related parameters according to LDL-cholesterol concentration ranges in non-diabetic patients
V. Kron, M. Verner, P. Smetana, R. Vrzalova, E. Friebergerova, D. Martinik, D. Horakova, L. Stepanek, L. Hamplova, K. Kotrbova
Language English Country Czech Republic
Document type Journal Article
PubMed
40145883
DOI
10.32725/jab.2025.005
Knihovny.cz E-resources
- MeSH
- C-Peptide * blood MeSH
- Adult MeSH
- Glucose Tolerance Test MeSH
- Insulin * blood MeSH
- Insulin Resistance * MeSH
- Blood Glucose * analysis metabolism MeSH
- Cholesterol, LDL * blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
The study focused on the changes in C-peptide, glycemia, insulin concentration, and insulin resistance according to LDL-cholesterol concentration ranges. The metabolic profile of individuals in the Czech Republic (n = 1840) was classified by quartiles of LDL-cholesterol into four groups with the following ranges: 0.46-2.45 (n = 445), 2.46-3.00 (n = 474), 3.01-3.59 (n = 459), and 3.60-7.18 mmol/l (n = 462). The level of glucose, C-peptide, insulin, and area of parameters during OGTT and HOMA IR were compared with a relevant LDL-cholesterol range. The evaluation involved correlations between LDL-cholesterol and the above parameters, F-test and t-test. Generally, mean values of glucose homeostasis-related parameters were higher with increasing LDL-cholesterol levels, except for mean HOMA IR values which rapidly increased (2.7-3.4) between LDL-cholesterol ranges of 3.00-3.59 and 3.60-7.18 mmol/l. Glucose, C-peptide, insulin concentrations, and the area of parameters reached greater changes especially after glucose load during OGTT (p ≤ 0.001). Considerable changes were already observed for the above parameters between groups with LDL-cholesterol ranges of 2.46-3.00 and 3.01-3.59 mmol/l. HOMA IR increased with higher LDL-cholesterol concentrations, but the differences in mean values were not statistically significant. Most important differences appeared in glucose metabolism at LDL-cholesterol concentrations of 3.60-7.18 mmol/l in comparison to LDL-cholesterol lower ranges. In particular, the areas of C-peptide, glucose, and insulin ranges showed statistically significant differences between all groups with growing LDL-cholesterol ranges. The variances of HOMA IR statistically differed between groups created according to LDL-cholesterol concentrations ranges.
Hospital of Ceske Budejovice a s Central Laboratories Ceske Budejovice Czech Republic
Institute of Laboratory Diagnostics and Public Health Ceske Budejovice Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25011860
- 003
- CZ-PrNML
- 005
- 20250521143002.0
- 007
- ta
- 008
- 250506s2025 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2025.005 $2 doi
- 035 __
- $a (PubMed)40145883
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kron, Vladimír $u University of South Bohemia in Ceske Budejovice, Faculty of Agriculture and Technology, Department of Food, Biotechnologies and Agricultural Products Quality, Ceske Budejovice, Czech Republic $u Ambulance for Metabolic Assessment of prof. MUDr. Karel Martinik, DrSc., s.r.o., Hradec Kralove, Czech Republic $u University of South Bohemia in Ceske Budejovice, Faculty of Science, Department of Medical Biology, Ceske Budejovice, Czech Republic $7 xx0258956
- 245 10
- $a Changes in glucose-related parameters according to LDL-cholesterol concentration ranges in non-diabetic patients / $c V. Kron, M. Verner, P. Smetana, R. Vrzalova, E. Friebergerova, D. Martinik, D. Horakova, L. Stepanek, L. Hamplova, K. Kotrbova
- 520 9_
- $a The study focused on the changes in C-peptide, glycemia, insulin concentration, and insulin resistance according to LDL-cholesterol concentration ranges. The metabolic profile of individuals in the Czech Republic (n = 1840) was classified by quartiles of LDL-cholesterol into four groups with the following ranges: 0.46-2.45 (n = 445), 2.46-3.00 (n = 474), 3.01-3.59 (n = 459), and 3.60-7.18 mmol/l (n = 462). The level of glucose, C-peptide, insulin, and area of parameters during OGTT and HOMA IR were compared with a relevant LDL-cholesterol range. The evaluation involved correlations between LDL-cholesterol and the above parameters, F-test and t-test. Generally, mean values of glucose homeostasis-related parameters were higher with increasing LDL-cholesterol levels, except for mean HOMA IR values which rapidly increased (2.7-3.4) between LDL-cholesterol ranges of 3.00-3.59 and 3.60-7.18 mmol/l. Glucose, C-peptide, insulin concentrations, and the area of parameters reached greater changes especially after glucose load during OGTT (p ≤ 0.001). Considerable changes were already observed for the above parameters between groups with LDL-cholesterol ranges of 2.46-3.00 and 3.01-3.59 mmol/l. HOMA IR increased with higher LDL-cholesterol concentrations, but the differences in mean values were not statistically significant. Most important differences appeared in glucose metabolism at LDL-cholesterol concentrations of 3.60-7.18 mmol/l in comparison to LDL-cholesterol lower ranges. In particular, the areas of C-peptide, glucose, and insulin ranges showed statistically significant differences between all groups with growing LDL-cholesterol ranges. The variances of HOMA IR statistically differed between groups created according to LDL-cholesterol concentrations ranges.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a LDL-cholesterol $x krev $7 D008078
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a krevní glukóza $x analýza $x metabolismus $7 D001786
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a C-peptid $x krev $7 D002096
- 650 12
- $a inzulin $x krev $7 D007328
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a glukózový toleranční test $7 D005951
- 650 _2
- $a senioři $7 D000368
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Verner, Miroslav, $d 1959- $u Hospital of Ceske Budejovice, a. s., Central Laboratories, Ceske Budejovice, Czech Republic $u University of South Bohemia in Ceske Budejovice, Faculty of Science, Department of Medical Biology, Ceske Budejovice, Czech Republic $7 jn20000402513
- 700 1_
- $a Smetana, Pavel, $d 1963- $u University of South Bohemia in Ceske Budejovice, Faculty of Agriculture and Technology, Department of Food, Biotechnologies and Agricultural Products Quality, Ceske Budejovice, Czech Republic $7 mzk2009521636
- 700 1_
- $a Vrzalová, Radka, $d 1976- $u University of South Bohemia in Ceske Budejovice, Faculty of Agriculture and Technology, Department of Food, Biotechnologies and Agricultural Products Quality, Ceske Budejovice, Czech Republic $7 _AN122555
- 700 1_
- $a Friebergerová, Eliška $u University of South Bohemia in Ceske Budejovice, Faculty of Agriculture and Technology, Department of Food, Biotechnologies and Agricultural Products Quality, Ceske Budejovice, Czech Republic $7 _AN122556
- 700 1_
- $a Martiník, Daniel $u Ambulance for Metabolic Assessment of prof. MUDr. Karel Martinik, DrSc., s.r.o., Hradec Kralove, Czech Republic $7 xx0270353
- 700 1_
- $a Horáková, Dagmar, $d 1970- $u Palacky University Olomouc, Faculty of Medicine and Dentistry, Department of Public Health, Olomouc, Czech Republic $7 xx0034367
- 700 1_
- $a Štěpánek, Ladislav $u Palacky University Olomouc, Faculty of Medicine and Dentistry, Department of Public Health, Olomouc, Czech Republic $7 xx0224068
- 700 1_
- $a Hamplová, Lidmila, $d 1960- $u Medical College, Prague 5, Czech Republic $7 mzk2014835208
- 700 1_
- $a Kotrbová, Kvetoslava, $d 1959- $u Institute of Laboratory Diagnostics and Public Health, Ceske Budejovice, Czech Republic $7 xx0224764
- 773 0_
- $w def $t Journal of applied biomedicine $x 1214-0287 $g Roč. 23, č. 1 (2025), s. 26-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40145883 $y Pubmed
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y p $z 0
- 990 __
- $a 20250506 $b ABA008
- 991 __
- $a 20250521143000 $b ABA008
- 999 __
- $a ok $b bmc $g 2324888 $s 1248950
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 23 $c 1 $d 26-35 $e 20250325 $i 1214-0287 $m Journal of applied biomedicine $n J Appl Biomed $x def
- LZP __
- $b NLK124 $a Pubmed-20250506